John P. Atkinson, … , Alan D. Schreiber, Michael M. Frank
Citation Information: J Clin Invest. 1973;52(6):1509-1517. https://doi.org/10.1172/JCI107325.
John P. Atkinson, … , Alan D. Schreiber, Michael M. Frank
Published June 1, 1973
Citation Information: J Clin Invest. 1973;52(6):1509-1517. https://doi.org/10.1172/JCI107325.
Abstract
Corticosteroids and splenectomy constitute two important therapeutic modalities in the treatment of autoimmune hemolytic anemia. Each of these may affect both the rate of synthesis of autoantibody and the clearance of antibody sensitized cells. The latter possibility has been examined in an experimental model which allows evaluation of the role of antibody and complement in the immune clearance of erythrocytes in molecular terms. The in vivo clearance of 51Cr-labeled guinea pig erythrocytes sensitized with purified rabbit IgG or IgM antibody to produce a known number of complement-fixing sites per cell was studied.
Authors
John P. Atkinson, Alan D. Schreiber, Michael M. Frank
Full Text PDF
Download PDF (1.95 MB)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)